stockrowPerspective Therapeutics, Inc. (CATX) vs Hyperfine, Inc. (HYPR)
- Perspective Therapeutics, Inc. CATX 0.86 +8.86%
- Hyperfine, Inc. HYPR 0.70 +1.45%
Perspective Therapeutics, Inc. and Hyperfine, Inc. are both Medical Devices companies. Perspective Therapeutics, Inc. is the larger, with a market value of $90.0M against $72.7M — 1.2× the size. Hyperfine, Inc. grew revenue faster over the last twelve months: 53.2% against −66.9%. Hyperfine, Inc. has the higher net margin (−210.8% vs −28,468.0%) and the lower return on invested capital (−401.8% vs −88.4%). Across the 18 metrics below, Hyperfine, Inc. leads on 10 and Perspective Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | CATX | HYPR | Medical Devices median |
|---|---|---|---|
| Gross margin | 100.00% | 51.41% | 57.76% |
| Operating margin | (30,619.07%) | (203.27%) | (15.07%) |
| Net margin | (28,467.97%) | (210.75%) | (14.45%) |
| Free cash flow margin | (29,630.07%) | (166.48%) | (3.88%) |
| Return on equity | (39.50%) | (96.97%) | (10.35%) |
| Return on assets | (33.14%) | (64.40%) | (17.26%) |
| Return on invested capital | (88.41%) | (401.79%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack